New Research Publication Sheds Light on Metastatic HR+/HER2- Breast Cancer Market Dynamics and 2032 Forecast
January 24, 2024 10:38 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032" report has been added to ResearchAndMarkets.com's...
HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032
January 24, 2024 10:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
Breast Cancer Drugs Global Market Report 2024, Featuring Profiles of Key Players Novartis, AstraZeneca, Eli Lilly, Biocon, Merck and MacroGenics
December 14, 2023 11:03 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The breast cancer drugs market size is set to to...
HER2 Inhibitors Global Market Report 2023: Featuring F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Boehringer-Ingelheim, Mylan & Biocon
April 07, 2023 07:03 ET
|
Research and Markets
Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global her2 inhibitors market is expected...
Trastuzumab Biosimilars Global Market Report 2022: Focus on Product Launches by Major Players Shaping Industry
September 27, 2022 04:58 ET
|
Research and Markets
Dublin, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The "Trastuzumab Biosimilars Global Market Report 2022: By Product, By Indication, By Distribution" report has been added to ResearchAndMarkets.com's...
Global HER2 Inhibitors Market Report (2022 to 2031) - Featuring Novartis, Pfizer and Puma Biotechnology Among Others
July 01, 2022 06:13 ET
|
Research and Markets
Dublin, July 01, 2022 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2022: By Treatment, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering. This...
The Worldwide Breast Cancer Drug Industry is Expected to Reach $27 Billion by 2026
March 09, 2022 06:58 ET
|
Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Global Breast Cancer Drug Market (2021-2026) by Drug Type, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19 with...
Global Breast Cancer Drugs Market (2021 to 2030) - Players Include Novartis, AstraZeneca and Celgene Among Others
November 11, 2021 06:58 ET
|
Research and Markets
Dublin, Nov. 11, 2021 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This...
Global Herceptin (Trastuzumab) Biosimilars Pipeline Guide 2021
October 22, 2021 04:53 ET
|
Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...
Global HER2 Inhibitors Market Report 2021-2025 & 2030 Featuring F. Hoffmann-La Roche., Merck, Novartis, Pfizer, Puma Biotechnology, Boehringer-Ingelheim, Mylan, and Biocon
October 20, 2021 08:58 ET
|
Research and Markets
Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...